Hospital-acquired bacterial pneumonia (HABP) and ventilator- associated bacterial pneumonia (VABP) in Canada:treatment update and the role of new IV antimicrobials

By sjmartinez • October 10, 2023

Rotstein C, Lynch JP 3rd, Zhanel GG. Hospital-acquired bacterial pneumonia (HABP) and ventilator- associated bacterial pneumonia (VABP) in Canada:treatment update and the role of new IV antimicrobials. Expert Rev Anti Infect Ther. 2023 Oct 9. doi: 10.1080/14787210.2023.2268287. Epub ahead of print. PMID: 37811572.

Tags: aminoglycosides, amoxicillin/clavulanate, carbapenems, ceftobiprole, ceftolozane/tazobactam, cephalosporins, combination therapy, dalbavancin and fosfomycin, fluoroquinolones, Monotherapy, penicillins, Publications, Pulmonary, Critical Care & Sleep Medicine

Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic review of outcomes

Stirrat T, Wilkey M, Ransibrahmanakul V, Singh L, Allen O, Kanth P, Rangnekar A, Redfield R. Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic[...]

Real-world clinical outcomes of Trastuzumab Deruxtecan in HER2-expressing ovarian and endometrial Cancer

Silverstein J, Alomaja O, Chatram D, Hajiabbasi M, Shachar E, Tseng CH, Thaker S, Bardia A, Karlan B, Hendrickson AW, Konecny GE. Real-world clinical outcomes[...]

Fixed-duration epcoritamab plus R-CHOP in newly diagnosed LBCL with IPI score 3-5: results from the EPCORE NHL-2 trial

Falchi L, Offner F, de Vos S, Brody JD, Morillo D, Linton K, Snauwaert S, Roost Clausen M, Karimi YH, Thieblemont C, Vitolo U, Leslie[...]